Literature DB >> 23813929

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Früh1, D De Ruysscher, S Popat, L Crinò, S Peters, E Felip.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23813929     DOI: 10.1093/annonc/mdt178

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  174 in total

1.  Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).

Authors:  Anna Sophie Berghoff; Gerda Ricken; Dorothee Wilhelm; Orsolya Rajky; Georg Widhalm; Karin Dieckmann; Peter Birner; Rupert Bartsch; Matthias Preusser
Journal:  J Neurooncol       Date:  2016-07-19       Impact factor: 4.130

Review 2.  A review of guidelines for lung cancer.

Authors:  Paolo Bironzo; Massimo Di Maio
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 3.  The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.

Authors:  Leora Horn; Martin Reck; David R Spigel
Journal:  Oncologist       Date:  2016-06-27

4.  Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients.

Authors:  Laura A Hatfield; Haiden A Huskamp; Elizabeth B Lamont
Journal:  J Oncol Pract       Date:  2016-06-28       Impact factor: 3.840

Review 5.  [Resection concepts for early stage neuroendocrine tumors of the lungs and bronchi].

Authors:  T Ploenes; C Aigner
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

6.  Upstaging, not just a non-small matter.

Authors:  Daniel C Thomas; Anthony W Kim
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

7.  Pathological upstaging and treatment strategy of clinical stage I small cell lung cancer following surgery.

Authors:  Hisashi Saji; Tomoyuki Miyazawa; Hideki Marushima; Haruhiko Nakamura
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

8.  Benefits of postoperative thoracic radiotherapy for small cell lung cancer subdivided by lymph node stage: a systematic review and meta-analysis.

Authors:  Shuling Zhang; Xin Sun; Li Sun; Zhicheng Xiong; Jietao Ma; Chengbo Han
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

9.  Prognostic Role of Lung Immune Scores for Prediction of Survival in Limited-stage Small Cell Lung Cancer.

Authors:  Leon SchnÖller; Lukas KÄsmann; Julian Taugner; Reem Abdo; Chukwuka Eze; Farkhad Manapov
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 10.  Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.

Authors:  Barbara Melosky; Parneet K Cheema; Anthony Brade; Deanna McLeod; Geoffrey Liu; Paul Wheatley Price; Kevin Jao; Devin D Schellenberg; Rosalyn Juergens; Natasha Leighl; Quincy Chu
Journal:  Oncologist       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.